{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:25:06Z","timestamp":1793953506462,"version":"4.8.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.pnpbp.2026.111692","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:36:19Z","timestamp":1775666179000},"page":"111692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pharmacokinetics-based management of newborns affected by hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia"],"prefix":"10.1016","volume":"146","author":[{"given":"Immacolata","family":"Rulli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Mattia","family":"Carcione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serafina","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Marseglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa","family":"Gitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pnpbp.2026.111692_bb0005","first-page":"232","article-title":"Effectiveness and safety of dexmedetomidine in neonates with hypoxic ischemic encephalopathy undergoing therapeutic hypothermia","volume":"29","author":"Acun","year":"2024","journal-title":"J Pediatr Pharmacol Ther."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111692_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-0037-1604392","article-title":"Hypotension and brain injury in asphyxiated newborns treated with hypothermia","volume":"35","author":"Al Balushi","year":"2018","journal-title":"Am J Perinatol."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111692_bb0015","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/jcph.70012","article-title":"From fragmented data to integrated drug development in asphyxiated neonates undergoing therapeutic hypothermia","volume":"65","author":"Allegaert","year":"2025","journal-title":"J Clin Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111692_bb0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00467-025-06957-1","article-title":"Progression of the estimated glomerular filtration rate in asphyxiated neonates undergoing therapeutic hypothermia during the first 10\u00a0days of life","volume":"41","author":"Allegaert","year":"2026","journal-title":"Pediatr Nephrol."},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111692_bb0025","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s12519-024-00836-9","article-title":"Neonatal encephalopathy due to suspected hypoxic ischemic encephalopathy: pathophysiology, current, and emerging treatments","volume":"20","author":"Babbo","year":"2024","journal-title":"World J Pediatr."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111692_bb0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13643-022-01982-9","article-title":"Interventions for the management of pain and sedation in newborns undergoing therapeutic hypothermia for hypoxic-ischemic encephalopathy (IPSNUT): protocol of a systematic review","volume":"11","author":"B\u00e4cke","year":"2022","journal-title":"Syst Rev."},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111692_bb0035","article-title":"Pharmacological interventions for pain and sedation management in newborn infants undergoing therapeutic hypothermia","volume":"11","author":"B\u00e4cke","year":"2022","journal-title":"Cochrane Database Syst Rev."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111692_bb0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40272-022-00546-7","article-title":"Interventions for the management of pain and sedation in newborns undergoing therapeutic hypothermia for hypoxic-ischemic encephalopathy: a systematic review","volume":"25","author":"B\u00e4cke","year":"2023","journal-title":"Paediatr Drugs"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111692_bb0045","article-title":"Dexmedetomidine use in infants undergoing cooling due to neonatal encephalopathy (DICE Trial): a randomized controlled trial: background, aims and study protocol","volume":"7","author":"Baserga","year":"2021","journal-title":"Front Pain Res (Lausanne)."},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111692_bb0050","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3390\/cells14110818","article-title":"Antioxidant bioactive agents for neuroprotection against perinatal brain injury","volume":"14","author":"Beretta","year":"2025","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111692_bb0055","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/bcp.12883","article-title":"PharmaCool study group. Altered gentamicin pharmacokinetics in term neonates undergoing controlled hypothermia","volume":"81","author":"Bijleveld","year":"2016","journal-title":"Br J Clin Pharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111692_bb0060","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/cpt.748","article-title":"Population pharmacokinetics of amoxicillin in term neonates undergoing moderate hypothermia","volume":"103","author":"Bijleveld","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111692_bb0065","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02311-17","article-title":"Evaluation of a system-specific function to describe the pharmacokinetics of benzylpenicillin in term neonates undergoing moderate hypothermia","volume":"62","author":"Bijleveld","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111692_bb0070","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.clp.2024.04.002","article-title":"Reverse therapy: impact of hyperthermia and rewarming on newborn outcomes","volume":"51","author":"Chalak","year":"2024","journal-title":"Clin Perinatol."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111692_bb0075","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/jcpt.12711","article-title":"Effect of hypothermia treatment on gentamicin pharmacokinetics in neonates with hypoxic-ischaemic encephalopathy: a systematic review and meta-analysis","volume":"43","author":"Choi","year":"2018","journal-title":"J Clin Pharm Ther."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111692_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000329818","article-title":"Effect of therapeutic hypothermia in neonates with hypoxic-ischemic encephalopathy on platelet function","volume":"101","author":"Christensen","year":"2012","journal-title":"Neonatology"},{"key":"10.1016\/j.pnpbp.2026.111692_bb0085","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/phar.1916","article-title":"Population pharmacokinetics and pharmacodynamic target attainment of ampicillin in neonates with Hypoxemic-Ischemic encephalopathy in the setting of controlled hypothermia","volume":"37","author":"Cies","year":"2017","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111692_bb0090","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/phar.2186","article-title":"Population pharmacokinetics of gentamicin in neonates with hypoxemic-ischemic encephalopathy receiving controlled hypothermia","volume":"38","author":"Cies","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111692_bb0095","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1038\/s41372-021-00998-8","article-title":"Dexmedetomidine versus intermittent morphine for sedation of neonates with encephalopathy undergoing therapeutic hypothermia","volume":"41","author":"Cosnahan","year":"2021","journal-title":"J Perinatol."},{"key":"10.1016\/j.pnpbp.2026.111692_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01282-17","article-title":"Amikacin pharmacokinetics to optimize dosing in neonates with perinatal asphyxia treated with hypothermia","volume":"61","author":"Cristea","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111692_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.siny.2021.101267","article-title":"Update on mechanisms of the pathophysiology of neonatal encephalopathy","volume":"26","author":"Davidson","year":"2021","journal-title":"Semin Fetal Neonatal Med."},{"key":"10.1016\/j.pnpbp.2026.111692_bb0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2431-12-45","article-title":"Pharmacokinetics and pharmacodynamics of medication in asphyxiated newborns during controlled hypothermia. The PharmaCool multicenter study","volume":"12","author":"de Haan","year":"2012","journal-title":"BMC Pediatr."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111692_bb0115","article-title":"Management of seizures in neonates with neonatal encephalopathy treated with hypothermia","volume":"26","author":"De La Garza-Pineda","year":"2021","journal-title":"Semin Fetal Neonatal Med"},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111692_bb0120","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s40262-021-00991-6","article-title":"Glomerular filtration rate in asphyxiated neonates under therapeutic whole-body hypothermia, quantified by mannitol clearance","volume":"60","author":"Deferm","year":"2021","journal-title":"Clin Pharmacokinet."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111692_bb0125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.siny.2017.07.008","article-title":"The use of phenobarbital and other anti-seizure drugs in newborns","volume":"22","author":"El-Dib","year":"2017","journal-title":"Semin Fetal Neonatal Med."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111692_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.siny.2021.101263","article-title":"Challenges in respiratory management during therapeutic hypothermia for neonatal encephalopathy","volume":"26","author":"El-Dib","year":"2021","journal-title":"Semin Fetal Neonatal Med"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111692_bb0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1542\/hpeds.2023-007403","article-title":"Dexmedetomidine during therapeutic hypothermia: a multicenter quality initiative","volume":"14","author":"Elliott","year":"2024","journal-title":"Hosp Pediatr."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111692_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211910","article-title":"Pharmacokinetics of morphine in encephalopathic neonates treated with therapeutic hypothermia","volume":"14","author":"Favi\u00e9","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111692_bb0145","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000499330","article-title":"Phenobarbital, midazolam pharmacokinetics, effectiveness, and drug-drug interaction in asphyxiated neonates undergoing therapeutic hypothermia","volume":"116","author":"Favi\u00e9","year":"2019","journal-title":"Neonatology"},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111692_bb0150","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/cpt.1917","article-title":"Prediction of drug exposure in critically ill encephalopathic neonates treated with therapeutic hypothermia based on a pooled population pharmacokinetic analysis of seven drugs and five metabolites","volume":"108","author":"Favi\u00e9","year":"2020","journal-title":"Clin Pharmacol Ther."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111692_bb0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/bcp.14136","article-title":"Lidocaine as treatment for neonatal seizures: Evaluation of previously developed population pharmacokinetic models and dosing regimen","volume":"86","author":"Favi\u00e9","year":"2020","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111692_bb0160","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022739","article-title":"Levetiracetam optimal dose-finding as first-line treatment for neonatal seizures occurring in the context of hypoxic-ischaemic encephalopathy (LEVNEONAT-1): study protocol of a phase II trial","volume":"9","author":"Favrais","year":"2019","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111692_bb0165","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1528-1167.2011.02978.x","article-title":"Phenobarbital for neonatal seizures in hypoxic ischemic encephalopathy: a pharmacokinetic study during whole body hypothermia","volume":"52","author":"Filippi","year":"2011","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111692_bb0170","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/14767058.2017.1304536","article-title":"Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI): a feasibility study","volume":"31","author":"Filippi","year":"2018","journal-title":"J Matern Fetal Neonatal Med."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111692_bb0175","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/pr.2014.19","article-title":"Effect of temperature on thromboelastography and implications for clinical use in newborns undergoing therapeutic hypothermia","volume":"75","author":"Forman","year":"2014","journal-title":"Pediatr Res."},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111692_bb0180","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/jp.2013.59","article-title":"Every 36-h gentamicin dosing in neonates with hypoxic-ischemic encephalopathy receiving hypothermia","volume":"33","author":"Frymoyer","year":"2013","journal-title":"J Perinatol."},{"key":"10.1016\/j.pnpbp.2026.111692_bb0185","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/phar.1263","article-title":"Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia","volume":"33","author":"Frymoyer","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pnpbp.2026.111692_bb0190","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/jcph.775","article-title":"Decreased morphine clearance in neonates with hypoxic ischemic encephalopathy receiving hypothermia","volume":"57","author":"Frymoyer","year":"2017","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111692_bb0195","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41390-020-01205-8","article-title":"Cardiovascular management following hypoxic-ischemic encephalopathy in North America: need for physiologic consideration","volume":"90","author":"Giesinger","year":"2021","journal-title":"Pediatr Res."},{"key":"10.1016\/j.pnpbp.2026.111692_bb0200","series-title":"StatPearls [Internet]","article-title":"Birth Asphyxia","author":"Gillam-Krakauer","year":"2024"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111692_bb0205","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s13760-020-01308-3","article-title":"Pathophysiology of hypoxic-ischemic encephalopathy: a review of the past and a view on the future","volume":"120","author":"Greco","year":"2020","journal-title":"Acta Neurol Belg."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111692_bb0210","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s00134-016-4344-1","article-title":"Clinical recommendations for pain, sedation, withdrawal and delirium assessment in critically ill infants and children: an ESPNIC position statement for healthcare professionals","volume":"42","author":"Harris","year":"2016","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.pnpbp.2026.111692_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1249700","article-title":"Perinatal asphyxia and hypothermic treatment from the endocrine perspective","volume":"14","author":"Improda","year":"2023","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111692_bb0220","doi-asserted-by":"crossref","first-page":"280.e1","DOI":"10.1016\/j.anpedi.2022.08.006","article-title":"Neonatal multiple organ failure after perinatal asphyxia","volume":"97","author":"Iribarren","year":"2022","journal-title":"An Pediatr (Engl Ed)."},{"key":"10.1016\/j.pnpbp.2026.111692_bb0225","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40268-016-0148-6","article-title":"An updated overview on therapeutic drug monitoring of recent antiepileptic drugs","volume":"16","author":"Jacob","year":"2016","journal-title":"Drugs R D"},{"key":"10.1016\/j.pnpbp.2026.111692_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003311.pub3","article-title":"Cooling for newborns with hypoxic ischaemic encephalopathy","author":"Jacobs","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111692_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0291170","article-title":"Analgesia and sedation strategies in neonates undergoing whole-body therapeutic hypothermia: a scoping review","volume":"18","author":"Joshi","year":"2023","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111692_bb0240","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1159\/000525574","article-title":"Serum creatinine patterns in neonates treated with therapeutic hypothermia for neonatal encephalopathy","volume":"119","author":"Keles","year":"2022","journal-title":"Neonatology"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111692_bb0245","first-page":"253","article-title":"Sedation and pain management in neonates undergoing therapeutic hypothermia for hypoxic-ischemic encephalopathy","volume":"12","author":"Kokhanov","year":"2025","journal-title":"Children (Basel)."},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111692_bb0250","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/s41372-022-01459-6","article-title":"Comparative evaluation of approach to cardiovascular care in neonatal encephalopathy undergoing therapeutic hypothermia","volume":"42","author":"Kovacs","year":"2022","journal-title":"J Perinatol."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111692_bb0255","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/17425255.2023.2237412","article-title":"Pharmacokinetics during therapeutic hypothermia in neonates: from pathophysiology to translational knowledge and physiologically-based pharmacokinetic (PBPK) modeling","volume":"19","author":"Leys","year":"2023","journal-title":"Expert Opin Drug Metab Toxicol."},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111692_bb0260","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3390\/biomedicines11092395","article-title":"Continuous fentanyl infusion in newborns with hypoxic-ischemic encephalopathy treated with therapeutic hypothermia: background, aims, and study protocol for time-concentration profiles","volume":"11","author":"Lugli","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111692_bb0265","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2020-000685","article-title":"Pharmacokinetics during therapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy: a literature review","volume":"4","author":"Lutz","year":"2020","journal-title":"BMJ Paediatr Open."},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111692_bb0270","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1007\/s00246-022-02916-x","article-title":"Effect of hypothermia on myocardial depolarization and repolarization in neonates with hypoxic-ischemic encephalopathy due to asphyxia","volume":"43","author":"Manabe","year":"2022","journal-title":"Pediatr Cardiol."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111692_bb0275","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/FTD.0b013e3182834335","article-title":"Gentamicin pharmacokinetics in neonates undergoing therapeutic hypothermia","volume":"35","author":"Mark","year":"2013","journal-title":"Ther Drug Monit."},{"key":"10.1016\/j.pnpbp.2026.111692_bb0280","first-page":"1","article-title":"Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimized dosing schedule","author":"Marques","year":"2019","journal-title":"Acta Paediatr"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111692_bb0285","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/apa.14944","article-title":"Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimized dosing schedule","volume":"109","author":"Marques","year":"2020","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.pnpbp.2026.111692_bb0290","article-title":"Dexmedetomidine pharmacokinetics in neonates with hypoxic-ischemic encephalopathy receiving hypothermia","volume":"2020","author":"McAdams","year":"2020","journal-title":"Anesthesiol Res Pract."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111692_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.siny.2021.101264","article-title":"Newborn Brain Society Guidelines and Publications Committee. Management of comfort and sedation in neonates with neonatal encephalopathy treated with therapeutic hypothermia","volume":"26","author":"McPherson","year":"2021","journal-title":"Semin Fetal Neonatal Med."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111692_bb0300","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3390\/biomedicines10020347","article-title":"Pathophysiology of perinatal asphyxia in humans and animal models","volume":"10","author":"Mota-Rojas","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111692_bb0305","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40272-024-00661-7","article-title":"Gentamicin pharmacokinetics in neonates undergoing therapeutic hypothermia for hypoxic ischemic encephalopathy","volume":"27","author":"Naik","year":"2025","journal-title":"Paediatr Drugs."},{"key":"10.1016\/j.pnpbp.2026.111692_bb0310","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/children5070099","article-title":"Current and emerging therapies in the management of hypoxic ischemic encephalopathy in neonates","volume":"5","author":"Nair","year":"2018","journal-title":"Children"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111692_bb0315","first-page":"352","article-title":"Dexmedetomidine versus fentanyl for neonates with hypoxic ischemic encephalopathy undergoing therapeutic hypothermia","volume":"27","author":"Naveed","year":"2022","journal-title":"J Pediatr Pharmacol Ther."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111692_bb0320","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1055\/s-0038-1669938","article-title":"Dexmedetomidine for sedation of neonates with HIE undergoing therapeutic hypothermia: a single-center experience","volume":"8","author":"O\u2019Mara","year":"2018","journal-title":"AJP Rep."},{"key":"10.1016\/j.pnpbp.2026.111692_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.earlhumdev.2022.105563","article-title":"Hemodynamic changes and evaluation during hypoxic-ischemic encephalopathy and therapeutic hypothermia","volume":"167","author":"Ovali","year":"2022","journal-title":"Early Hum Dev."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111692_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.siny.2020.101139","article-title":"Optimizing hemodynamic care in neonatal encephalopathy","volume":"25","author":"Pang","year":"2020","journal-title":"Semin Fetal Neonatal Med."},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111692_bb0335","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3389\/fped.2020.00512","article-title":"Blood pressure profiles in infants with hypoxic ischemic encephalopathy (HIE), response to dopamine, and association with brain injury","volume":"26","author":"Pazandak","year":"2020","journal-title":"Front Pediatr."},{"key":"10.1016\/j.pnpbp.2026.111692_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106029","article-title":"Olfactory testing in infants with perinatal asphyxia: enhancing encephalopathy risk stratification for future health outcomes","volume":"169","author":"Perrone","year":"2025","journal-title":"Neurosci Biobehav Rev."},{"issue":"39","key":"10.1016\/j.pnpbp.2026.111692_bb0345","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.2174\/1381612821666150901110929","article-title":"The impact of hypothermia on the pharmacokinetics of drugs used in neonates and young infants","volume":"21","author":"Pokorna","year":"2015","journal-title":"Curr Pharm Des."},{"issue":"14","key":"10.1016\/j.pnpbp.2026.111692_bb0350","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1080\/14767058.2018.1432039","article-title":"Severity of asphyxia is a covariate of phenobarbital clearance in newborns undergoing hypothermia","volume":"32","author":"Pokorn\u00e1","year":"2019","journal-title":"J Matern Fetal Neonatal Med."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111692_bb0355","doi-asserted-by":"crossref","first-page":"107","DOI":"10.23736\/S2724-5276.20.05740-0","article-title":"Severity parameters for asphyxia or hypoxic-ischemic encephalopathy do not explain inter-individual variability in the pharmacokinetics of phenobarbital in newborns treated with therapeutic hypothermia","volume":"74","author":"Pokorn\u00e1","year":"2022","journal-title":"Minerva Pediatr."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111692_bb0360","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.clp.2016.04.006","article-title":"Cardiovascular alterations and multiorgan dysfunction after birth asphyxia","volume":"43","author":"Polglase","year":"2016","journal-title":"Clin Perinatol."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111692_bb0365","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41372-023-01802-5","article-title":"Efficacy and safety of dexmedetomidine for analgesia and sedation in neonates: a systematic review","volume":"44","author":"Portelli","year":"2024","journal-title":"J Perinatol."},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111692_bb0370","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1111\/epi.17745","article-title":"Treatment of seizures in the neonate: Guidelines and consensus-based recommendations-Special report from the ILAE Task Force on Neonatal Seizures","volume":"64","author":"Pressler","year":"2023","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111692_bb0375","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.clp.2016.04.002","article-title":"Pathophysiology of birth asphyxia","volume":"43","author":"Rainaldi","year":"2016","journal-title":"Clin Perinatol."},{"issue":"18","key":"10.1016\/j.pnpbp.2026.111692_bb0380","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1080\/14767058.2017.1344633","article-title":"Effect of therapeutic hypothermia on myocardial dysfunction in term neonates with perinatal asphyxia - a randomized controlled trial","volume":"31","author":"Rakesh","year":"2018","journal-title":"J Matern Fetal Neonatal Med."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111692_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.siny.2021.101277","article-title":"Newborn Brain Society Guidelines and Publications Committee. Hemodynamic optimization for neonates with neonatal encephalopathy caused by a hypoxic ischemic event: Physiological and therapeutic considerations","volume":"26","author":"Rios","year":"2021","journal-title":"Semin Fetal Neonatal Med."},{"key":"10.1016\/j.pnpbp.2026.111692_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.880786","article-title":"diastolic dysfunction in neonates with hypoxic-ischemic encephalopathy during therapeutic hypothermia: a tissue doppler study","volume":"10","author":"Rodriguez","year":"2022","journal-title":"Front Pediatr."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111692_bb0395","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/FTD.0000000000000056","article-title":"Predictive performance of a gentamicin population pharmacokinetic model in neonates receiving full-body hypothermia","volume":"36","author":"Sampson","year":"2014","journal-title":"Ther Drug Monit."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111692_bb0400","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17202-7","article-title":"Evolution of energy related metabolites in plasma from newborns with hypoxic-ischemic encephalopathy during hypothermia treatment","volume":"7","author":"S\u00e1nchez-Illana","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.pnpbp.2026.111692_bb0405","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/PCC.0b013e31825bbbc2","article-title":"Population pharmacokinetics of phenobarbital in infants with neonatal encephalopathy treated with therapeutic hypothermia","volume":"14","author":"Shellhaas","year":"2013","journal-title":"Pediatr Crit Care Med"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111692_bb0410","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jpeds.2013.06.012","article-title":"Factors associated with permanent hearing impairment in infants treated with therapeutic hypothermia","volume":"163","author":"Smit","year":"2013","journal-title":"J Pediatr."},{"key":"10.1016\/j.pnpbp.2026.111692_bb0415","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3389\/fphar.2020.00587","article-title":"A physiology-based pharmacokinetic framework to support drug development and dose precision during therapeutic hypothermia in neonates","volume":"11","author":"Smits","year":"2020","journal-title":"Front Pharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111692_bb0420","first-page":"891","article-title":"Respiratory management during therapeutic hypothermia for hypoxic-ischemic encephalopathy. J Perinatol. 2019;39(6):763\u2013773. doi:10.1038\/s41372-019-0349-2. Epub 2019 Mar 11","volume":"39","author":"Szakmar","year":"2019","journal-title":"Erratum in: J Perinatol"},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111692_bb0425","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/jcph.70004","article-title":"Population pharmacokinetics of caffeine in infants with hypoxic-ischemic encephalopathy: a phase I, dose-escalating trial","volume":"65","author":"Thompson","year":"2025","journal-title":"J Clin Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111692_bb0430","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12098-014-1527-z","article-title":"Pharmacokinetics of gentamicin in newborns with moderate-to-severe hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia","volume":"82","author":"Ting","year":"2015","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.pnpbp.2026.111692_bb0435","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1128\/AAC.02374-13","article-title":"Characterization of the population pharmacokinetics of ampicillin in neonates using an opportunistic study design","volume":"58","author":"Tremoulet","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111692_bb0440","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s40262-012-0004-y","article-title":"Pharmacokinetics and clinical efficacy of phenobarbital in asphyxiated newborns treated with hypothermia: a thermopharmacological approach","volume":"51","author":"van den Broek","year":"2012","journal-title":"Clin Pharmacokinet."},{"key":"10.1016\/j.pnpbp.2026.111692_bb0445","doi-asserted-by":"crossref","first-page":"F341","DOI":"10.1136\/archdischild-2012-302678","article-title":"Anticonvulsant treatment of asphyxiated newborns under hypothermia with lidocaine: efficacy, safety and dosing","volume":"98","author":"van den Broek","year":"2013","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.pnpbp.2026.111692_bb0450","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000368180","article-title":"Anticonvulsant effectiveness and hemodynamic safety of midazolam in full-term infants treated with hypothermia","volume":"107","author":"van den Broek","year":"2015","journal-title":"Neonatology"},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111692_bb0455","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01707-22","article-title":"Population pharmacokinetics and dosing optimization of ceftazidime in term asphyxiated neonates during controlled therapeutic hypothermia","volume":"67","author":"van der Veer","year":"2023","journal-title":"Antimicrob Agents Chemother."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111692_bb0460","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/FTD.0000000000001166","article-title":"Predictive performance of a gentamicin pharmacokinetic model in term neonates with perinatal asphyxia undergoing controlled therapeutic hypothermia","volume":"46","author":"van der Veer","year":"2024","journal-title":"Ther Drug Monit."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111692_bb0465","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/bcp.16026","article-title":"Population pharmacokinetics of vancomycin in term neonates with perinatal asphyxia treated with therapeutic hypothermia","volume":"90","author":"van der Veer","year":"2024","journal-title":"Br J Clin Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111692_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247403","article-title":"Effect of therapeutic hypothermia on renal and myocardial function in asphyxiated (near) term neonates: a systematic review and meta-analysis","volume":"16","author":"van Wincoop","year":"2021","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111692_bb0475","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/jcph.70003","article-title":"Mathematical albumin function for neonates undergoing therapeutic hypothermia in comparison with control neonates","volume":"65","author":"Vander Elst","year":"2025","journal-title":"J Clin Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111692_bb0480","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/0883073816678102","article-title":"Levetiracetam for the treatment of seizures in neonatal hypoxic ischemic encephalopathy","volume":"32","author":"Venkatesan","year":"2017","journal-title":"J Child Neurol."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111692_bb0485","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.siny.2014.10.003","article-title":"Analgesics, sedatives, anticonvulsant drugs, and the cooled brain","volume":"20","author":"Wassink","year":"2015","journal-title":"Semin Fetal Neonatal Med."},{"key":"10.1016\/j.pnpbp.2026.111692_bb0490","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1055\/s-0033-1358749","article-title":"Disposition of midazolam in asphyxiated neonates receiving therapeutic hypothermia\u2013a pilot study","volume":"225","author":"Welzing","year":"2013","journal-title":"Klin Padiatr"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111692_bb0495","first-page":"348","article-title":"Gentamicin dosing in therapeutic hypothermia; a quality improvement initiative","volume":"109","author":"Whitla","year":"2016","journal-title":"Ir Med J."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111692_bb0500","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1177\/0271678X15607881","article-title":"The effects of therapeutic hypothermia on cerebral metabolism in neonates with hypoxic-ischemic encephalopathy: An in vivo 1H-MR spectroscopy study","volume":"36","author":"Wisnowski","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111692_bb0505","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.siny.2014.10.005","article-title":"Physiological responses to hypothermia","volume":"20","author":"Wood","year":"2015","journal-title":"Semin Fetal Neonatal Med."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111692_bb0510","article-title":"Hemodynamic changes in neonatal hypoxic-ischemic encephalopathy requiring therapeutic hypothermia. Eur J Pediatr. 2026 185(2):93. doi:10.1007\/s00431-026-06754-4","volume":"185","author":"Yu","year":"2026","journal-title":"Erratum in: Eur J Pediatr."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111692_bb0515","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jp.2010.146","article-title":"Physiologic and pharmacologic considerations for hypothermia therapy in neonates","volume":"31","author":"Zanelli","year":"2011","journal-title":"J Perinatol."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111692_bb0520","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2025-073627","article-title":"Therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy: clinical report","volume":"157","author":"Zanelli","year":"2026","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111692_bb0525","article-title":"Therapeutic hypothermia increases the risk of cardiac arrhythmia for perinatal hypoxic ischaemic encephalopathy: a meta-analysis","volume":"12","author":"Zhang","year":"2017","journal-title":"PLoS One"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626000898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626000898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:36:55Z","timestamp":1793950615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584626000898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":105,"alternative-id":["S0278584626000898"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111692","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics-based management of newborns affected by hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111692","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111692"}}